Pretomanid Market Gains Momentum as Global Efforts to Combat Drug-Resistant Tuberculosis Intensify
https://growthmarketreports.co....m/report/pretomanid-
The Pretomanid Market is witnessing steady growth as healthcare systems worldwide strengthen their response to drug-resistant tuberculosis (T. Pretomanid is an important anti-tuberculosis medication used in combination therapies for treating multidrug-resistant (MDR-T and extensively drug-resistant tuberculosis (XDR-T, supporting improved treatment outcomes and patient care.